Replies to post #2713 on RedHill Biopharma Ltd (RDHL)

[midastouch017]

You ignore this part:

Like Aemcolo, its launch has been negatively impacted by the pandemic and sales have been anemic. The company did not elect to break out Talicia sales in its 3Q20 earnings report, only stating that prescriptions grew 300% sequentially over 2Q20 and total commercial and government lives covered reached 167 million Americans. Between Talicia and Aemcolo, 3Q20 sales were ~$1.5 million.

Some companies have benefitted from the pandemic, others
have suffered. RDHL is one of the unfortunate.
You might say that RDHL is spread too thin on too many
products, hence the need for the frequent dilution, but
this policy does have its advantages.

[midastouch017]

BTW Amatuer17 your comments are
most welcome. It makes me think!

:-)